Mark de Groot

4.5k total citations
81 papers, 1.6k citations indexed

About

Mark de Groot is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark de Groot has authored 81 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 18 papers in Surgery and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark de Groot's work include Cardiovascular Function and Risk Factors (7 papers), Pharmacovigilance and Adverse Drug Reactions (6 papers) and Advanced MRI Techniques and Applications (6 papers). Mark de Groot is often cited by papers focused on Cardiovascular Function and Risk Factors (7 papers), Pharmacovigilance and Adverse Drug Reactions (6 papers) and Advanced MRI Techniques and Applications (6 papers). Mark de Groot collaborates with scholars based in Netherlands, Germany and United States. Mark de Groot's co-authors include Ulrich O. von Oppell, Olaf H. Klungel, A.C. van Grootheest, Stefan Neubauer, Saskia Haitjema, Michael Horn, Linda Härmark, H.E. van der Wiel, Robert F. Reynolds and Jan Jelrik Oosterheert and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mark de Groot

79 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark de Groot Netherlands	24	350	263	245	236	163	81	1.6k
Steven M. Belknap United States	22	505 1.4×	367 1.4×	206 0.8×	295 1.3×	182 1.1×	60	2.4k
Moro O. Salifu United States	26	479 1.4×	330 1.3×	248 1.0×	431 1.8×	86 0.5×	160	2.3k
Craig Newcomb United States	28	360 1.0×	402 1.5×	111 0.5×	321 1.4×	115 0.7×	76	2.8k
Ivar S. Nordrum Norway	23	387 1.1×	151 0.6×	174 0.7×	268 1.1×	169 1.0×	60	1.4k
Curtis A. Parvin United States	33	442 1.3×	435 1.7×	368 1.5×	175 0.7×	235 1.4×	98	2.8k
Jerome Lowenstein United States	22	260 0.7×	248 0.9×	483 2.0×	241 1.0×	198 1.2×	64	2.0k
Rabi Yacoub United States	23	203 0.6×	199 0.8×	366 1.5×	198 0.8×	106 0.7×	46	1.6k
Edward Chia‐Cheng Lai Taiwan	28	408 1.2×	411 1.6×	294 1.2×	329 1.4×	220 1.3×	162	3.1k
Giorgio Fuíano Italy	32	317 0.9×	405 1.5×	378 1.5×	461 2.0×	88 0.5×	126	2.4k
Melissa G. Butler United States	24	242 0.7×	203 0.8×	224 0.9×	172 0.7×	96 0.6×	64	1.7k

Countries citing papers authored by Mark de Groot

Since Specialization

Citations

This map shows the geographic impact of Mark de Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark de Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark de Groot more than expected).

Fields of papers citing papers by Mark de Groot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark de Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark de Groot. The network helps show where Mark de Groot may publish in the future.

Co-authorship network of co-authors of Mark de Groot

This figure shows the co-authorship network connecting the top 25 collaborators of Mark de Groot. A scholar is included among the top collaborators of Mark de Groot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark de Groot. Mark de Groot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Groot, Olivier Q., Mark de Groot, Joanne M. van der Velden, et al.. (2025). External validation of 12 existing survival prediction models for patients with spinal metastases. The Spine Journal. 25(7). 1347–1359.

Groot, Olivier Q., Mark de Groot, Joanne M. van der Velden, et al.. (2025). Predicting quality of life of patients after treatment for spinal metastatic disease: development and internal evaluation. The Spine Journal. 25(7). 1371–1385. 1 indexed citations

Veldkamp, Saskia R, Mark de Groot, Saskia Haitjema, et al.. (2025). Persistent hypogammaglobulinemia after rituximab therapy in pediatric patients, prevalence and clinical outcomes. SHILAP Revista de lepidopterología. 7. 55–63. 1 indexed citations

Gardarsdóttir, Helga, Marcel Kwa, Jadwiga Wójkowska‐Mach, et al.. (2024). Use of antibiotics in the early COVID-19 pandemic in Poland, the Netherlands and Spain, from erraticism to (more) logic. European Journal of Clinical Pharmacology. 80(10). 1581–1589. 1 indexed citations

Groenhof, T. Katrien J., Mark de Groot, Wouter W. van Solinge, et al.. (2022). A Wolf in Sheep’s Clothing: Reuse of Routinely Obtained Laboratory Data in Research. Journal of Medical Internet Research. 24(11). e40516–e40516. 7 indexed citations

Groot, Mark de, Gerard Pasterkamp, Hester M. den Ruijter, et al.. (2021). Preventing unnecessary imaging in patients suspect of coronary artery disease through machine learning of electronic health records. European Heart Journal - Digital Health. 3(1). 11–19. 12 indexed citations

Laban, Kamil G., Rachel Kalmann, Cornelis P. J. Bekker, et al.. (2019). A pan‐inflammatory microRNA‐cluster is associated with orbital non‐Hodgkin lymphoma and idiopathic orbital inflammation. European Journal of Immunology. 50(1). 86–96. 6 indexed citations

Harder, Annemarie M. den, Pim A. de Jong, Mark de Groot, et al.. (2018). Commonly available hematological biomarkers are associated with the extent of coronary calcifications. Atherosclerosis. 275. 166–173. 8 indexed citations

Kofink, Daniel, Riyaz Patel, Jannick A N Dorresteijn, et al.. (2018). Routinely measured hematological parameters and prediction of recurrent vascular events in patients with clinically manifest vascular disease. PLoS ONE. 13(9). e0202682–e0202682. 12 indexed citations

10.

Groot, Mark de, et al.. (2017). Trends in breast cancer incidence among women with type-2 diabetes in British general practice. Primary care diabetes. 11(4). 373–382. 9 indexed citations

11.

Brauer, Ruth, Ian Douglas, Luis A. Garcı́a Rodrı́guez, et al.. (2016). Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case–control studies using two primary care databases in Europe. Pharmacoepidemiology and Drug Safety. 25(S1). 29–38. 13 indexed citations

12.

Veldhuis‐Vlug, Annegreet G., Ling Oei, Patrick C. Souverein, et al.. (2015). Association of polymorphisms in the beta-2 adrenergic receptor gene with fracture risk and bone mineral density. Osteoporosis International. 26(7). 2019–2027. 12 indexed citations

13.

Groenwold, Rolf H. H., et al.. (2015). Unmeasured confounding in pharmacoepidemiology. Annals of Epidemiology. 26(1). 85–86. 9 indexed citations

14.

Rottenkolber, Marietta, Liset van Dijk, Paola Primatesta, et al.. (2015). Time Trends of Period Prevalence Rates of Patients with Inhaled Long-Acting Beta-2-Agonists-Containing Prescriptions: A European Comparative Database Study. PLoS ONE. 10(2). e0117628–e0117628. 9 indexed citations

15.

Groot, Mark de, et al.. (2010). Genetic polymorphisms related to the renin–angiotensin–aldosterone system and response to antihypertensive drugs. Expert Opinion on Drug Metabolism & Toxicology. 6(4). 439–460. 15 indexed citations

16.

Härmark, Linda, H.E. van der Wiel, Mark de Groot, & A.C. van Grootheest. (2007). Proton pump inhibitor‐induced acute interstitial nephritis. British Journal of Clinical Pharmacology. 64(6). 819–823. 80 indexed citations

17.

Groot, Mark de & Eugène van Puijenbroek. (2007). Clindamycin and taste disorders. British Journal of Clinical Pharmacology. 64(4). 542–545. 7 indexed citations

18.

Groot, Mark de. (2001). Akupunktur: Komplikationen, Kontraindikationen und Patientenaufklärung. Complementary Medicine Research. 8(5). 256–262. 10 indexed citations

19.

Groot, Mark de, Nicolaas de Jonge, C. Klöpping, et al.. (1999). Myocardial high-energy phosphate metabolism in heart transplant patients is temporarily altered irrespective of rejection. NMR in Biomedicine. 12(8). 515–524. 7 indexed citations

20.

Bruinsma, George J. Brandon Bravo, Marcel G.J. Nederhoff, Mark de Groot, et al.. (1999). Bio-energetic response of the heart to dopamine following brain death–related reduced myocardial workload: A phosphorus-31 magnetic resonance spectroscopy study in the cat. The Journal of Heart and Lung Transplantation. 18(12). 1189–1197. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact